This meeting took place in 2013


Here are the related meetings in 2019:
Drivers of Type 2 Diabetes: From Genes to Environment (S1)
Diabetes: Innovations, Outcomes and Personalized Therapies (X3)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Diabetes — New Insights into Mechanism of Disease and its Treatment (J6)


Organizer(s) C. Ronald Kahn, Jens C. Brüning and Gerald I. Shulman
January 27—February 1, 2013
Keystone Resort • Keystone, Colorado USA
Abstract Deadline: Sep 27, 2012
Late Abstract Deadline: Oct 29, 2012
Scholarship Deadline: Sep 27, 2012
Early Registration Deadline: Nov 28, 2012

Sponsored by EMD Millipore, MedImmune and Nestlé Institute of Health Sciences


Summary of Meeting:
We are in the midst of an epidemic of type 2 diabetes and the closely related metabolic syndrome. These disorders come from a complete interaction between genes and environment which is not fully understood. The goals of this meeting are to address important new areas of research into the primary pathogenesis of these disorders and especially focus on those that might lead to new therapies. The major topics of the meeting are: 1) Mechanisms of metabolic dysfunction and new therapeutic targets for diabetes and obesity; 2) miRNAs in control of metabolism; 3) Aging, mitochondria, and control of metabolism; 4) Epigenetics and perinatal imprinting in diabetes and obesity; 5) CNS control of metabolism; 6) Gastric bypass surgery and the gut in control of metabolism; 7) Metabolic mediators of insulin resistance; and 8) Signaling defects and inflammation in insulin resistance. The major goals of this meeting are to: 1) Make investigators of aware of important new advances in the field of diabetes research; 2) Bring new topics of research from outside the field to the diabetes research community; 3) Stimulate interactions and potential collaborations between participants; and 4) Bring lessons from clinical practice back to the bench. The program should bring new scientific knowledge, new methods and new insights from clinical practice together to stimulate interchange of ideas and even collaborations. Although this meeting has been a regular annual event in the Keystone Symposia series, many of the topics and speakers are new and thus will enrich the field in new ways. The Keystone Symposia Diabetes meeting remains the most important forum for new basic science presentations in the field of diabetes. By bringing it together with the conference on Adipocyte Biology and having multiple joint sessions, this meeting fill a need in the scientific community that is not filled by other conferences. The meeting has novel content that will inform and challenge the attendees and brings many new research paradigms, as well as novel approaches and methods to the scientific community. The meeting is truly interdisciplinary, with not only basic scientists and clinical scientists, but those from many disciplines outside the fields of endocrinology and metabolism, including gastroenterology, neuroscience, innate immunity and genetics.

View Meeting Program

Scholarships/Awards

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)/National Institute on Aging (NIA) Scholarship Recipients

Dave Bridges
University of Michigan, USA

Ning Dai
Harvard Medical School, USA

Yingfeng Deng
University of Texas Southwestern Medical Center, USA

Leah Eissing
University Medical Center Hamburg-Eppendorf, Germany

Teppei Fujikawa
University of Texas Southwestern Medical Center, USA

Congcong He
Northwestern University, USA

Mads Fuglsang Kjolby
Aarhus University, Denmark

Ara Koh
Gothenburg University, Sweden

Fiona McMurray
MRC Harwell, UK

Mufaddal S. Soni
University of Wisconsin-Madison, USA

Jonathon N. Winnay
Joslin Diabetes Center, USA